NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

Seems to me you’re blaming the nature of the biotech business on a CEO. Drugs cost up to 1 billion dollars to trial and develop in today’s world. Thus, if you have a unique idea, you need a bunch of money and a bunch of time to go through phases of trials to get to approval. Any CEO of any developmental biotech is going to lose money until there’s a commercial product. Late phase 3 means the time is quite near for approval and commercialization. I’d expect any developmental biotech to be running on fumes at this point after a 10 year trial. Our CEO has us 10 years ahead of the closest competitor. How much is that worth with a successful product in biotech? We may be about to find out.